Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-06-07 Sale |
2023-06-09 7:12 pm |
FIBROGEN INC | FGEN | Eisner Mark EVP, Chief Medical Officer |
2,042 | $17.04 | $34,792 | 162,862 (Direct) |
View |
| 2023-06-02 Sale |
2023-06-05 4:22 pm |
FIBROGEN INC | FGEN | Eisner Mark EVP, Chief Medical Officer |
1,090 | $18.83 | $20,525 | 164,904 (Direct) |
View |
| 2023-04-04 Sale |
2023-04-06 4:32 pm |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
9,182 | $18.78 | $172,473 | 165,994 (Direct) |
View |
| 2023-03-08 Sale |
2023-03-10 9:55 pm |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
17,503 | $20.6 | $360,572 | 175,176 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 4:59 pm |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
1,187 | $21.87 | $25,960 | 172,496 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-22 Option Award |
2025-02-25 3:39 pm |
N/A 2035-02-21 |
Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer |
120,000 | $0 | 195,000 (Direct) |
View |
| 2024-07-15 Option Award |
2024-07-16 4:40 pm |
N/A 2034-07-14 |
Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer |
225,000 | $0 | 225,000 (Direct) |
View |
Ownership |
2024-06-03 11:57 am |
N/A N/A |
Vir Biotechnology Inc. | VIR | Eisner Mark EVP and Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |
| 2023-09-06 Tax Withholding |
2023-09-08 4:59 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark EVP, Chief Medical Officer |
1,860 | $0.9631 | 159,917 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-06 8:55 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark EVP, Chief Medical Officer |
1,085 | $1.06 | 161,777 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 9:55 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
20,183 | $0 | 175,176 (Direct) |
View |
| 2023-02-21 Option Award |
2023-02-23 8:38 pm |
N/A 2033-02-20 |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
87,500 | $0 | 228,683 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 5:41 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
1,084 | $15.04 | 141,183 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-04 5:21 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
6,777 | $13.01 | 142,267 (Direct) |
View |
| 2022-09-01 Tax Withholding |
2022-09-02 5:30 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
756 | $13.09 | 149,044 (Direct) |
View |
| 2022-06-01 Tax Withholding |
2022-06-03 4:21 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
1,141 | $9.61 | 149,800 (Direct) |
View |
| 2022-03-31 Tax Withholding |
2022-04-01 7:28 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
6,442 | $12.02 | 150,941 (Direct) |
View |
| 2022-03-01 Tax Withholding |
2022-03-03 4:04 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
756 | $13.62 | 157,383 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-16 9:01 pm |
N/A 2032-02-13 |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
160,000 | $0 | 258,139 (Direct) |
View |
| 2022-01-03 Tax Withholding |
2022-01-05 4:44 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
7,043 | $14.82 | 98,139 (Direct) |
View |
| 2021-12-01 Tax Withholding |
2021-12-03 4:03 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
4,338 | $12.65 | 105,182 (Direct) |
View |
| 2021-10-04 Option Award |
2021-10-06 7:25 pm |
N/A 2031-10-04 |
FIBROGEN INC | FGEN | Eisner Mark Chief Medical Officer |
119,040 | $0 | 154,040 (Direct) |
View |
| 2020-12-01 Option Award |
2020-12-03 6:51 pm |
N/A 2030-12-01 |
FIBROGEN INC | FGEN | Eisner Mark Incoming Chief Medical Officer |
115,000 | $0 | 115,000 (Direct) |
View |
Ownership |
2020-12-03 6:41 pm |
N/A N/A |
FIBROGEN INC | FGEN | Eisner Mark Incoming Chief Medical Officer |
0 | $0 | 0 (Direct) |
View |